Important Safety Information
Before you receive Radicava™ (edaravone), tell your healthcare provider about all of your medical conditions, including if you:
- have asthma.
- are allergic to other medicines.
- are pregnant or plan to become pregnant. It is not known if Radicava™ will harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known if Radicava™ passes into your breastmilk. You and your healthcare provider should decide if you will receive Radicava™ or breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of Radicava™?
- Radicava™ may cause serious side effects, including hypersensitivity (allergic) reactions and sulfite allergic reactions.
- Hypersensitivity reactions have happened in people receiving Radicava™ and can happen after your infusion is finished.
- Radicava™ contains sodium bisulfite, a sulfite that may cause a type of allergic reaction that can be serious and life-threatening. Sodium bisulfite can also cause less severe asthma episodes in certain people. Sulfite sensitivity can happen more often in people who have asthma than in people who do not have asthma.
- Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; wheezing; trouble swallowing; dizziness; itching; or an asthma attack (in people with asthma).
- Your healthcare provider will monitor you during treatment to watch for signs and symptoms of all the serious side effects.
The most common side effects of Radicava™ include bruising (contusion), problems walking (gait disturbance), and headache.
These are not all the possible side effects of Radicava™. Call your healthcare provider for medical advice about side effects. You may report side effects to MT Pharma America, Inc. at 1-888-292-0058 or FDA at 1-800-FDA-1088 or
Radicava™ is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
Please see full Prescribing Information and Patient Information.